Is HMB (Beta-Hydroxy Beta-Methylbutyrate) Good? Nutrition & Benefits
Fine in moderation · The honest verdict
Okay in the right context
Health score
62/100
Health score: 62 out of 100.
HMB has its strongest clinical evidence in muscle-wasting populations — a 2022 AJCN meta-analysis found strong evidence for improved strength (SMD 0.31) but borderline evidence for lean mass gains — while its benefit for healthy trained athletes is limited and inconsistent; it is theoretically relevant to GLP-1-associated muscle loss but has no GLP-1-specific trial data.
HMB is a metabolite of the essential amino acid leucine that has been studied for decades as a supplement to preserve muscle mass and improve strength. The evidence is genuinely promising for people at risk of muscle wasting — the elderly, those recovering from surgery or illness, and people with conditions like cancer cachexia — but the same benefits don't reliably translate to healthy, trained athletes who eat enough protein. For GLP-1 users concerned about lean mass loss, HMB's anti-catabolic mechanism is theoretically interesting, but protein and resistance training remain the only evidence-backed strategy.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Benefits, honestly graded
Each claim gets an evidence grade so you can tell a well-studied effect from a hopeful one — the label competitors skip.
Muscle mass and strength in clinical muscle-wasting conditions
Moderate evidence2022 AJCN meta-analysis found strong evidence for strength improvement (SMD 0.31) and borderline evidence for lean mass gains; effects most consistent in sarcopenic, elderly, or clinically wasted populations
Reduced exercise-induced muscle damage
Limited evidenceSome trials show reduced CK and soreness markers in untrained or older subjects; less consistent in trained athletes
Muscle gain in trained athletes
Limited evidenceBenefits are inconsistent in trained populations; some trials positive, many null; effect size smaller than creatine in available head-to-head data
What's actually inside
Per Typically 1 g capsule or tablet × 3 daily (3 g/day total; varies by brand). Protein and fiber are the numbers that matter most when your appetite is smaller — they do the heavy lifting on fullness.
Protein
0g
keeps you full, protects muscle
Fiber
0g
slows digestion, steadies appetite
Added sugar
0g
the number to keep low
- Calories
- 0kcal
- Total carbs
- 0g
- Total sugars
- 0g
- Fat
- 0g
- Saturated fat
- 0g
- Sodium
- 0mg
Dosing in plain terms
General reference points only — the label on your product and your clinician are the authority on what's right for you.
3 g/day chronically as Ca-HMB, typically 1 g three times daily with meals (per systematic reviews); free-acid form (HMB-FA) may load faster but has a smaller RCT base; effects accumulate over weeks to months; no acute or loading-phase benefit
Safety & side effects
Most people tolerate it well, but every supplement has trade-offs. The serious signs below are rare and need prompt attention.
Usually mild
Common effects
- Very well tolerated; no significant GI or other common side effects reported across trials
Rare — seek care
Serious signs
- None well-documented; safety profile described as strong in systematic reviews
What this means for your plan
GLP-1 drugs cause significant lean mass loss (26–45% of total weight lost is lean mass per recent DXA sub-studies). HMB's dual anti-catabolic mechanism — reducing ubiquitin-proteasome-mediated muscle protein breakdown and stimulating mTOR — is theoretically aligned with this problem. However, there are no published RCTs of HMB specifically in GLP-1-treated patients, and the Mozaffarian et al. 2025 joint advisory recommends protein at 1.2–2.0 g/kg/day plus resistance training as the primary strategy, with no mention of HMB. Not a GLP-1 substitute.
What Is HMB and Why Does Your Body Make It Naturally?
HMB — beta-hydroxy beta-methylbutyrate — isn't some lab-created molecule foreign to your body. It's a natural metabolite of leucine, the same essential amino acid that triggers muscle protein synthesis after a protein-rich meal. About 5% of the leucine you consume gets converted to HMB, which means your body already makes roughly 0.2 to 0.4 grams of it every day from a normal diet. The supplement dose of 3 grams daily is pharmacological — roughly 10 times what your body produces on its own — which is why researchers have spent decades asking whether that extra HMB does anything meaningful.
HMB acts primarily on skeletal muscle through two distinct mechanisms. The first is anti-catabolic: HMB inhibits the ubiquitin-proteasome pathway, the cellular machinery that tags muscle proteins for breakdown and disposal. Think of it as putting a lock on the door that muscle protein walks out of. The second mechanism is anabolic: HMB stimulates the mTOR pathway, the same growth-signaling cascade that leucine itself activates, which tells muscle cells to build new protein. This dual action — slowing breakdown while nudging growth — is what makes HMB theoretically appealing for anyone worried about losing muscle.
The catch is that these mechanisms were mostly demonstrated in situations where muscle breakdown was already elevated — illness, aging, prolonged inactivity. In a healthy person eating adequate protein and training regularly, the ubiquitin-proteasome system isn't running wild, and mTOR is already getting stimulated by dietary leucine. Adding more HMB on top of that may be like adding an extra lock to a door that was never being forced open in the first place.
Bottom line
HMB's dual anti-catabolic and anabolic mechanism is biologically plausible; the question is whether the supplement dose produces meaningful effects in people already eating adequate leucine-rich complete protein.
The Meta-Analysis Evidence: Strong for Strength, Borderline for Mass
The most authoritative synthesis of HMB research to date is a 2022 meta-analysis published in the American Journal of Clinical Nutrition, which pooled data from multiple randomized controlled trials across diverse populations. The headline finding: HMB supplementation produced a standardized mean difference (SMD) of 0.31 for strength outcomes, which the authors classified as 'strong evidence.' For lean body mass, the evidence was weaker — statistically borderline, meaning the effect was small enough that it could plausibly be noise.
What does an SMD of 0.31 mean in practical terms? It's a small-to-moderate effect. For context, creatine monohydrate typically produces SMDs in the 0.4 to 0.6 range for strength in healthy trained populations — roughly double the effect size. And here's the crucial detail that supplement marketing almost never mentions: the HMB meta-analysis's positive results were driven disproportionately by studies in elderly, sarcopenic, or clinically wasted subjects. When you isolate the trials on healthy, trained athletes eating adequate protein, the effect shrinks further and often loses statistical significance entirely.
This pattern makes biological sense. HMB's anti-catabolic mechanism matters most when muscle breakdown is pathologically elevated. In a 70-year-old with sarcopenia who struggles to eat enough protein, HMB may genuinely slow the loss. In a 25-year-old athlete consuming 1.6 grams of protein per kilogram daily and squatting twice a week, the ubiquitin-proteasome system isn't the limiting factor — and adding HMB doesn't move the needle in a way that matters. The meta-analysis authors themselves noted that the strength evidence was robust but that the clinical significance varied dramatically by population.
Bottom line
The evidence base says HMB genuinely helps people who are losing muscle in clinical contexts; for healthy trained athletes eating adequate protein, the benefit is far less convincing.
HMB vs Creatine: The Honest Head-to-Head
If you're a healthy adult trying to get stronger or build muscle, the comparison between HMB and creatine monohydrate isn't close. Creatine has hundreds of randomized controlled trials supporting its use for strength, power output, and lean mass gains in healthy, trained populations. The effect sizes are consistently moderate to large. The safety record spans decades. And creatine monohydrate costs roughly 5 to 10 cents per gram, compared to HMB which can run 50 cents to over a dollar per gram depending on the brand and form.
The practical protocols differ too. Creatine works with a loading phase of 20 grams daily for 5–7 days followed by 3–5 grams daily maintenance, and you'll see performance effects within a week or two. HMB requires 3 grams daily taken chronically — effects accumulate over weeks to months, and there's no acute benefit. You can't take HMB before a workout and expect anything to happen. It's a long-game supplement, and even then, the game it's playing is muscle preservation, not muscle building.
Could you take both? Theoretically, yes — they work through different mechanisms, and there's no known negative interaction. But for a healthy athlete on a budget, the question is whether HMB adds anything beyond what creatine and adequate protein already provide. The evidence doesn't support that it does. Creatine plus protein gives you the anabolic stimulus and the cellular energy to train harder; HMB's anti-catabolic contribution is redundant when muscle breakdown isn't elevated in the first place.
Bottom line
Creatine beats HMB on every practical metric for healthy athletes; HMB's niche is muscle-wasting prevention in clinical or high-risk populations where creatine alone may be insufficient.
Who Is Actually Most Likely to Benefit from HMB?
The populations where HMB shows the most consistent, clinically meaningful effects share a common thread: they're losing muscle faster than their bodies can rebuild it, and the usual solutions — eating more protein and training harder — aren't fully available to them. Elderly adults with age-related sarcopenia are the best-studied group. As we age, we become less sensitive to dietary amino acids (a phenomenon called anabolic resistance), and HMB appears to partially bypass that resistance by directly inhibiting muscle protein breakdown.
People recovering from prolonged bed rest, major surgery, or severe illness represent another high-benefit group. When you're immobilized, muscle atrophy accelerates dramatically — you can lose significant quadriceps mass in just days of disuse. HMB's anti-catabolic mechanism is directly relevant here, and several trials in post-surgical and bed-rest populations have shown preservation of lean mass compared to placebo. Cancer cachexia and HIV-related wasting are additional clinical contexts with positive trial data, though these are specialized medical situations where HMB would be used under clinical supervision, not as an over-the-counter fitness supplement.
The common denominator is inadequate protein intake or inability to exercise. If someone can't eat enough complete protein — whether due to appetite loss, medical restrictions, or practical barriers — HMB may partially compensate by reducing the rate of muscle breakdown. If someone can't resistance train — due to injury, illness, or severe deconditioning — HMB may help slow the loss until they can. But for someone who can do both, the evidence suggests HMB adds little to nothing.
Bottom line
HMB's best-evidenced use case is people who cannot train adequately or eat enough protein — not healthy athletes who can do both.
HMB and GLP-1 Medications: A Theoretically Interesting but Unproven Pairing
GLP-1 receptor agonists like semaglutide and tirzepatide produce remarkable weight loss, but a significant portion of that weight isn't fat. A 2024 DXA sub-study of the STEP 1 trial found that approximately 45% of the weight lost on semaglutide was lean mass. A 2025 analysis of SURMOUNT-1 data reported that about 26% of weight lost on tirzepatide 15 mg was lean mass. These aren't trivial numbers — losing muscle alongside fat can reduce metabolic rate, compromise functional strength, and potentially worsen long-term body composition if the weight is regained.
This is where HMB's mechanism becomes theoretically interesting. GLP-1 drugs cause weight loss primarily by reducing calorie intake, and when the body is in a significant calorie deficit, muscle protein breakdown increases. HMB's ability to inhibit the ubiquitin-proteasome pathway could, in theory, help preserve lean mass during GLP-1-induced weight loss. The mTOR stimulation might also help, though that pathway is already dampened in a calorie deficit regardless of supplementation. The problem is that theory isn't evidence — there are zero published randomized controlled trials testing HMB specifically in people taking GLP-1 medications.
The 2025 joint advisory from leading obesity and nutrition researchers is explicit about what actually works: protein intake of 1.2 to 2.0 grams per kilogram of body weight daily, combined with resistance training at least three times per week. This recommendation doesn't mention HMB, not because HMB is dangerous, but because the evidence for protein and resistance training is vastly stronger. If you're on a GLP-1 medication and concerned about muscle loss, your first, second, and third priorities should be hitting your protein target and lifting weights. HMB might eventually prove to be a useful adjunct — the mechanism is plausible enough that clinical trials are warranted — but for now, it's an unproven add-on, not a substitute for the basics.
Bottom line
HMB is theoretically the most GLP-1-relevant non-protein supplement because of its anti-catabolic mechanism — but there are no trials in GLP-1 patients yet, and protein plus resistance training remains the primary evidence-based strategy.
What most pages leave out
HMB is heavily marketed with selective citation of studies in clinical and sarcopenic populations to imply general athletic benefit. The honest read of the 2022 AJCN meta-analysis is that there is strong evidence for strength improvement (SMD 0.31) and only borderline evidence for lean mass gains — and this was driven largely by non-athlete populations. For healthy trained athletes eating adequate complete protein, the evidence for HMB is weak. Competitors almost never disclose this population specificity.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
HMB (beta-hydroxy beta-methylbutyrate) is a metabolite of the essential amino acid leucine. It works through two main mechanisms: inhibiting the ubiquitin-proteasome pathway to reduce muscle protein breakdown, and stimulating the mTOR pathway to promote muscle protein synthesis. Most of the clinical evidence for its effectiveness comes from populations experiencing muscle wasting, such as the elderly or those recovering from illness.
The evidence is mixed and highly population-dependent. A 2022 meta-analysis in the American Journal of Clinical Nutrition found strong evidence for strength improvement (SMD 0.31) but only borderline evidence for lean mass gains, with effects driven largely by elderly and clinical populations. In healthy, trained athletes eating adequate protein, the evidence for muscle building is weak and inconsistent.
The standard dose studied in clinical trials is 3 grams per day of Ca-HMB (the calcium salt form), typically split into three 1-gram doses taken with meals. Effects accumulate over weeks to months of consistent use. The free-acid form (HMB-FA) is also available but has a smaller body of research behind it.
No. For healthy adults seeking strength and muscle gains, creatine monohydrate has stronger and broader evidence, larger effect sizes, and costs dramatically less per gram. HMB may have a role in clinical muscle-wasting contexts where creatine alone is insufficient, but it is not a superior general-purpose supplement.
HMB's anti-catabolic mechanism is theoretically relevant to the lean mass loss seen with GLP-1 medications, but there are no published clinical trials testing HMB specifically in GLP-1 users. The evidence-based strategy for preserving muscle during GLP-1 treatment is adequate protein intake (1.2–2.0 g/kg/day) combined with resistance training.
HMB has a strong safety profile based on available clinical trials. It is very well tolerated, with no significant gastrointestinal or other side effects consistently reported. No serious adverse events have been attributed to HMB supplementation in the research literature.
HMB is not an acute supplement — you won't notice anything from a single dose. Effects on strength and lean mass accumulate over weeks to months of consistent daily use. This is a chronic supplementation strategy, not something you take for an immediate performance boost.
The populations with the strongest evidence for benefit are elderly adults with sarcopenia, people recovering from surgery or prolonged bed rest, and individuals with clinical muscle-wasting conditions who cannot eat enough protein or exercise adequately. Healthy, trained athletes eating sufficient protein are the least likely to see meaningful benefit.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Beta-Alanine: Causes and Treatment
Beta-alanine has no recognized deficiency syndrome. Learn why the tingling side effect is harmless, who might benefit from supplementation, and what GLP-1 users need to know.
Read moreHow Beta-Alanine Interacts with Weight-Loss Medications
No direct drug interaction, but beta-alanine's harmless tingling can mimic hypoglycemia on GLP-1s. Learn the real risk, dosing, and how to stay safe.
Read moreSymptoms of Low HMB (Beta-Hydroxy Beta-Methylbutyrate): Causes and Treatment
HMB is a leucine metabolite, not an essential nutrient — no deficiency syndrome exists. Learn what the evidence says about HMB for muscle preservation during aging or weight loss.
Read moreSymptoms of Low Beta-Sitosterol: Causes and Treatment
Beta-sitosterol is not an essential nutrient and has no recognized deficiency syndrome. Learn about its evidence for BPH and LDL cholesterol, plus the rare genetic disorder where it accumulates.
Read moreHow HMB (Beta-Hydroxy-Beta-Methylbutyrate) Interacts with Weight-Loss Medications
Does HMB interact with semaglutide or tirzepatide? A clinical review of safety, lean-mass preservation, and practical dosing during GLP-1 therapy.
Read moreHow Beta-Sitosterol Interacts With Weight Loss Medications
How beta-sitosterol interacts with GLP-1 medications like semaglutide and tirzepatide. Covers LDL-lowering benefits, fat-soluble vitamin depletion risks, and safe co-use.
Read moreOn a GLP-1, or thinking about one?
Eating well is the foundation. For some people, a GLP-1 medication is the tool that finally makes appetite manageable.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.